Ximbio - Your Global Reagents Partner

Ximbio

Life Science Companies
Technology Transfer Offices
Research Scientists

Leverage Ximbio’s existing global relationships with universities and research institutes to source novel and unique reagents.

Learn More

Benefit from our existing relationships with more than 200 life science companies. Ximbio's extensive resources make the commercialisation of reagents simple.

Learn More

Generate income, source useful reagents for your experiments and reduce your administration burden. Partner with Ximbio to commercialise your reagents, at no cost to you.

Learn More

Our Reagent Portfolio

Search for a specific reagent or browse reagents by category.

Monoclonal Antibodies

2054

Polyclonal Antibodies

220

Cell Lines

690

Mouse Models

247

Small Molecules (Tool Compounds)

230

Vectors

3549

Peptides and Proteins

Zebrafish

Recombinant Antibodies

137

Lab Consumables

Bacteria

Latest Updates

/img/e29a734b-5e39-4cbb-af5c-71ce8135d9ea.png

Plasmax vs DMEM: the impact of physiologically relevant cell culture media

14 October 2021 Read more »

/img/982fc22b-e182-4298-8bbf-8fc396b5ee58.png

Accelerate research discoveries beyond your lab

24 August 2021 Read more »

View all news and events

We’re excited to announce that the Cancer Research UK Lung Cancer Conference will return later this year, with @CRUKLungCentre leads Prof Caroline Dive and Prof @CharlesSwanton. #CRUKLung22

Register your interest today and be the first to find out more: https://t.co/eUoGAJuIXZ pic.twitter.com/Fey7btTVKN

— Science and Innovation at Cancer Research UK (@CRUKresearch) January 24, 2022

Check this on Twitter